<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:42:31Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3229840" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:3229840</identifier><datestamp>2011-12-05</datestamp><setSpec>blackwellopen</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Cell Physiol</journal-id>
      <journal-id journal-id-type="publisher-id">jcp</journal-id>
      <journal-title-group>
        <journal-title>Journal of Cellular Physiology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0021-9541</issn>
      <issn pub-type="epub">1097-4652</issn>
      <publisher>
        <publisher-name>Wiley Subscription Services, Inc., A Wiley Company</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC3229840</article-id>
      <article-id pub-id-type="pmcid">PMC3229840</article-id>
      <article-id pub-id-type="pmc-uid">3229840</article-id>
      <article-id pub-id-type="pmid">21302310</article-id>
      <article-id pub-id-type="doi">10.1002/jcp.22667</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Alternative Splicing of <italic>CARMA2/CARD14</italic> Transcripts Generates Protein Variants With Differential Effect on NF-ÎºB Activation and Endoplasmic Reticulum Stress-Induced Cell Death</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Scudiero</surname>
            <given-names>Ivan</given-names>
          </name>
          <xref ref-type="aff" rid="au1">1</xref>
          <xref ref-type="aff" rid="au2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zotti</surname>
            <given-names>Tiziana</given-names>
          </name>
          <xref ref-type="aff" rid="au1">1</xref>
          <xref ref-type="aff" rid="au2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ferravante</surname>
            <given-names>Angela</given-names>
          </name>
          <xref ref-type="aff" rid="au1">1</xref>
          <xref ref-type="aff" rid="au2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vessichelli</surname>
            <given-names>Mariangela</given-names>
          </name>
          <xref ref-type="aff" rid="au1">1</xref>
          <xref ref-type="aff" rid="au2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vito</surname>
            <given-names>Pasquale</given-names>
          </name>
          <xref ref-type="aff" rid="au1">1</xref>
          <xref ref-type="aff" rid="au2">2</xref>
          <xref ref-type="corresp" rid="cor1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stilo</surname>
            <given-names>Romania</given-names>
          </name>
          <xref ref-type="aff" rid="au1">1</xref>
          <xref ref-type="aff" rid="au2">2</xref>
        </contrib>
      </contrib-group>
      <aff id="au1">
        <label>1</label>
        <institution>Biogem</institution>
        <addr-line>Ariano Irpino, Italy</addr-line>
      </aff>
      <aff id="au2">
        <label>2</label>
        <institution>Dipartimento di Scienze Biologiche ed Ambientali, UniversitÃ  degli Studi del Sannio</institution>
        <addr-line>Benevento, Italy</addr-line>
      </aff>
      <author-notes>
        <corresp id="cor1">*Correspondence to: Pasquale Vito, Dipartimento di Scienze Biologiche ed Ambientali, UniversitÃ  degli Studi del Sannio, Via Port'Arsa 11, 82100 Benevento, Italy E-mail: <email>vito@unisannio.it</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>12</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>02</day>
        <month>2</month>
        <year>2011</year>
      </pub-date>
      <volume>226</volume>
      <issue>12</issue>
      <fpage>3121</fpage>
      <lpage>3131</lpage>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>8</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>1</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright Â© 2011 Wiley-Liss, Inc., A Wiley Company</copyright-statement>
        <copyright-year>2011</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/">
          <license-p>Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>The caspase recruitment domain (CARD)-containing proteins CARMA1-3 share high degree of sequence, structure and functional homology. Whereas CARMA1 and CARMA3 have been identified as crucial components of signal transduction pathways that lead to activation of NF-ÎºB transcription factor, little is known about the function of CARMA2. Here we report the identification of two splice variants of CARMA2. One transcript, named CARMA2<italic>short</italic> (CARMA2<italic>sh</italic>), is predicted to encode for a CARMA2 polypeptide containing the CARD, coiled coil, and a PDZ domains, but lacking the SH3 and the GuK domains. The second variant, CARMA2<italic>cardless</italic> (CARMA2<italic>cl</italic>), encodes for a polypeptide lacking the CARD domain and containing only a portion of the coiled coil domain and a linker region. Expression analysis confirmed the presence of the CARMA2 alternatively spliced transcripts in both human cell lines and tissues. Fluorescence microscopy data show that both splice variants localize in the cytosol. Biochemical experiments indicate that CARMA2<italic>sh</italic> interacts with TRAF2 and activates NF-ÎºB in a TRAF2-dependent manner. Finally, CARMA2<italic>sh</italic> variant protects cells from apoptosis induced by different stimuli. Taken together, these results demonstrate that multiple transcripts encoding several CARMA2 isoforms exist in vivo and regulate NF-ÎºB activation and apoptosis. J. Cell. Physiol. 226: 3121â3131, 2011. Â© 2011 Wiley Periodicals, Inc.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <p>The caspase recruitment domain (CARD)-containing proteins CARMA1 (CARD11/Bimp2) (Bertin et al., <xref ref-type="bibr" rid="b1">2001</xref>; Gaide et al., <xref ref-type="bibr" rid="b5">2001</xref>; Wang et al., <xref ref-type="bibr" rid="b25">2001</xref>), CARMA2 (CARD14/Bimp3) (Bertin et al., <xref ref-type="bibr" rid="b1">2001</xref>), and CARMA3 (CARD10/Bimp1) (Wang et al., <xref ref-type="bibr" rid="b25">2001</xref>; McAllister-Lucas et al., <xref ref-type="bibr" rid="b15">2001</xref>) share a high degree of sequence, structure, and functional homology. CARMA proteins belong to the membrane-associated guanylate kinase (MAGUK) family of proteins, which can function as molecular scaffolds that assist recruitment and assembly of signal transduction molecules (Dimitratos et al., <xref ref-type="bibr" rid="b2">1999</xref>). CARMA proteins contain a CARD domain, a Src-homology 3 (SH3) domain, one or several PDZ domains and a GuK domain (Bertin et al., <xref ref-type="bibr" rid="b1">2001</xref>; Gaide et al., <xref ref-type="bibr" rid="b5">2001</xref>; Wang et al., <xref ref-type="bibr" rid="b25">2001</xref>; McAllister-Lucas et al., <xref ref-type="bibr" rid="b15">2001</xref>). Genetic and biochemical studies have identified CARMA1 as crucial component of a complex of proteins that links antigen receptors on B and T lymphocytes to activation of NF-ÎºB (Wang et al., <xref ref-type="bibr" rid="b26">2002</xref>; Gaide et al., <xref ref-type="bibr" rid="b6">2002</xref>; Pomerantz et al., <xref ref-type="bibr" rid="b18">2002</xref>; Hara et al., <xref ref-type="bibr" rid="b10">2003</xref>; Egawa et al., <xref ref-type="bibr" rid="b4">2003</xref>; Newton and Dixit, <xref ref-type="bibr" rid="b17">2003</xref>; Jun et al., <xref ref-type="bibr" rid="b11">2003</xref>). This complex, which includes CARMA1, BCL10, MALT1, and TRAF6, has been shown to activate the IKK complex through an ubiquitylation-dependent pathway (Schulze-Luehrmann and Ghosh, <xref ref-type="bibr" rid="b20">2006</xref>).</p>
    <p>A second member of the CARMA family, CARMA3, is required for activation of NF-ÎºB induced by G-protein-coupled receptors (GPCRs) (Grabiner et al., <xref ref-type="bibr" rid="b7">2007</xref>; McAllister-Lucas et al., <xref ref-type="bibr" rid="b16">2007</xref>). In fact, it has been demonstrated that a complex of proteins, including CARMA3, BCL10, and MALT1, appears to be responsible for transmitting the signal from the GPCRs to the IKK complex (Grabiner et al., <xref ref-type="bibr" rid="b7">2007</xref>; McAllister-Lucas et al., <xref ref-type="bibr" rid="b16">2007</xref>). By contrast, although overexpression of CARMA2 also induces NF-ÎºB activation in HEK-293 cells (Bertin et al., <xref ref-type="bibr" rid="b1">2001</xref>), the signaling pathway(s) regulated by this protein is still unknown. Here we describe the identification of two splice variants of CARMA2 and show data indicating an involvement of these proteins in regulation of NF-ÎºB activation and endoplasmic reticulum (ER)-stress induced cell death.</p>
    <sec>
      <title>Results</title>
      <p>Previous work identified CARMA2/CARD14 (CARMA2FL) as a 1,004 amino acidic residues protein belonging to the CARMA family of proteins (Bertin et al., <xref ref-type="bibr" rid="b1">2001</xref>). To examine the occurrence of splice variants derived from the human <italic>CARMA2</italic> gene, we performed an extensive reverse transcription-polymerase chain reaction (RT-PCR) analysis of mRNAs isolated from human cell lines using <italic>CARMA2/CARD14</italic> exon-specific primers.</p>
      <p>Such analysis revealed the existence of two different splice variants of <italic>CARMA2/CARD14</italic>. One variant contains the same translational start of CARMA2FL but includes an additional exon (<italic>alternative exon 15</italic>) containing an alternative stop codon. This transcript is predicted to encode for a polypeptide corresponding to amino acids 1â740 of CARMA2FL, and therefore we named this variant CARMA2<italic>short</italic> (CARMA2<italic>sh</italic>) (<xref ref-type="fig" rid="fig01">Fig. 1A,B</xref>). The second variant mRNA skips exons 1â4, contains an alternative translational start codon in exon 5 and includes an additional exon containing an alternative stop codon (<xref ref-type="fig" rid="fig01">Fig. 1A,B</xref>). The <italic>CARMA2</italic> isoform encoded by this splice variant would lack the CARD domain, includes amino acids Met<sup>238</sup>-Val<sup>618</sup> of CARMA2FL and contains a unique carboxy terminus (<xref ref-type="fig" rid="fig01">Fig. 1A,B</xref>). We named this variant CARMA2<italic>cardless</italic> (CARMA2<italic>cl</italic>).</p>
      <fig id="fig01" position="float">
        <label>Fig. 1</label>
        <caption>
          <p><italic>CARMA2</italic> isoforms. A: Amino acid alignment of CARMA2FL, CARMA2<italic>sh</italic>, and CARMA2<italic>cl</italic>. The unique sequence of CARMA2<italic>cl</italic> is in bold. B: Schematic representation of CARMA2FL, CARMA2<italic>sh</italic>, and CARMA2<italic>cl</italic> isoforms.</p>
        </caption>
        <graphic xlink:href="jcp0226-3121-f1"/>
      </fig>
      <p>To confirm the existence of these alternatively spliced transcripts of <italic>CARMA2</italic>, we performed RT-PCR on mRNAs isolated from different human normal and tumoral cell lines and normal tissues using internal primers that can distinguish each of the splice variants. Using a primer set specific for exon 15 and the alternative exon 15, we detected a PCR product that corresponds to the predicted size of a fragment derived from transcripts encoding CARMA2<italic>sh</italic> (<xref ref-type="fig" rid="fig02">Fig. 2A</xref>). This transcript was expressed in most of the cell lines tested, in human fetal brain and human leucocytes (<xref ref-type="fig" rid="fig02">Fig. 2A</xref>).</p>
      <fig id="fig02" position="float">
        <label>Fig. 2</label>
        <caption>
          <p><italic>CARMA2</italic> isoform expression. A: RT-PCR was used to analyze CARMA2 transcripts in a part of cDNA from various human tissues and cell lines. These comprised human lung carcinoma (NCI-H226, DMS-79, CALU1, NCI-H526, SHP77, A549, NCI-H460, NCI-H1975, NCI-H292, and NCI-H2009) mesothelioma (NCI-H28) normal epithelial (SAEC, NHBE), Burkitt's limphoma (Raji), colon carcinoma (HT29), monocitic leukemia (THP1), bronchial carcinoma (BEN), T cell leukemia (Jurkat), and cervical carcinoma (HeLa). Where indicated, cells were stimulated with tumor necrosis factor Î± (TNFÎ±) or thiazolidinedione (TZD) before RNA extraction. Identity of amplicons was confirmed by DNA sequencing. B: Specificity of the antiserum to CARMA2 used in this study. HEK-293 cells were transfected with a vector that was empty or expressing FLAG-tagged CARMA2<italic>sh</italic>. Twenty-four hours later, cell lysates were separated by SDSâPAGE and transferred onto membranes subsequently probed with anti-FLAG mAb, affinity-purified anti-CARMA2 rabbit antiserum or preimmune rabbit serum, as indicated. C: Cell lysates were prepared from HeLa and HEK-293 cells, separated by SDSâPAGE, and transferred onto membranes subsequently probed with anti-CARMA2 antisera.</p>
        </caption>
        <graphic xlink:href="jcp0226-3121-f2"/>
      </fig>
      <p>We also confirmed the presence of the transcript coding for CARMA2<italic>cl</italic> using a primer within the 5â²-untranslated region paired with a reverse primer located in exon 5. The CARMA2<italic>cl</italic> transcript was expressed only in HeLa cells (<xref ref-type="fig" rid="fig02">Fig. 2A</xref>).</p>
      <p>To study these CARMA2 splice variants, we generated a polyclonal rabbit antibody directed against a polypeptide corresponding to aa 108â407 of CARMA2 FL (<xref ref-type="fig" rid="fig02">Fig. 2B</xref>). When probed on cell lysates prepared from HeLa and HEK-293 cells, the antisera detected bands corresponding to the predicted size of endogenous CARMA2FL, CARMA2<italic>sh</italic>, and CARMA2<italic>cl</italic> isoforms. The antisera also recognizes additional bands, indicating that other splice variants of CARMA2 may occur (<xref ref-type="fig" rid="fig02">Fig. 2C</xref>).</p>
      <p>Because CARMA proteins are implicated in NF-ÎºB signaling pathways, we first determined whether CARMA2<italic>sh</italic> and CARMA<italic>cl</italic> can induce NF-ÎºB activity using a luciferase reporter assay. When CARMA2<italic>sh</italic> was expressed in HEK-293 cells, NF-ÎºB activity was induced at least 20- to 40-fold compared with empty vector (<xref ref-type="fig" rid="fig03">Fig. 3A</xref>). In the same assay, CARMA<italic>cl</italic> was unable to promote NF-ÎºB activity, thus confirming that the N-terminal CARD domain of CARMA proteins is essential for NF-ÎºB signaling (<xref ref-type="fig" rid="fig03">Fig. 3A</xref>).</p>
      <fig id="fig03" position="float">
        <label>Fig. 3</label>
        <caption>
          <p>CARMA2<italic>sh</italic> interacts with BCL10. A: HEK-293 cells were transiently cotransfected with an expression vector encoding for the indicated polypeptides, together with pNF-ÎºB-luc and pRSV-Î²gal reporter vectors. The total amount of transfected plasmidic DNA was maintained constant by adding empty vector. Sixteen hours after transfection, cell lysates were prepared and luciferase activity was measured. Data shown represent relative luciferase activity normalized on Î²-galactosidase activity and is representative of six independent experiments done in triplicate. Statistical analysis was by the one-tailed unpaired Student's <italic>t</italic>-test. B: The indicated expression vectors were transfected as in (A) in HEK-293 cells expressing a shRNA targeting BCL10. Expression of BCL10 was monitored by immunoblot assay (bottom part). Statistical analysis was by the one-tailed unpaired Student's <italic>t</italic>-test. C: HEK-293 cells were transiently cotransfected with a FLAG-tagged version of CARMA2<italic>sh</italic> (left parts) or CARMA2<italic>cl</italic> (right parts) along with HA-tagged version of wt and point mutants of BCL10, as indicated. Twenty-four hours later, cell lysates were immunoprecipitated with anti-FLAG mAb. Immunocomplexes were separated by SDSâPAGE and transferred onto membranes subsequently probed with anti-HA antisera.</p>
        </caption>
        <graphic xlink:href="jcp0226-3121-f3"/>
      </fig>
      <p>It has been shown that CARMA3, a member of the CARMA family of proteins, is unable to activate NF-ÎºB in the absence of functional BCL10 (Wang et al., <xref ref-type="bibr" rid="b25">2001</xref>). To test whether also CARMA2<italic>sh</italic> requires BCL10 for the NF-ÎºB-inducing activity, CARMA2<italic>sh</italic> was tested in HEK-293 cells expressing a short hairpin RNA (shRNA) designed to target BCL10 for degradation by the RNAi pathway. The results of these experiments indicate that, likewise CARMA3, CARMA2<italic>sh</italic> as well depends on functional BCL10 to induce NF-ÎºB (<xref ref-type="fig" rid="fig03">Fig. 3B</xref>). Similarly to CARMA1 and CARMA3 (Stilo et al., <xref ref-type="bibr" rid="b22">2008</xref>), activation of NF-ÎºB mediated by CARMA2<italic>sh</italic> was inhibited by expression of A20 (data not shown).</p>
      <p>Biochemical data confirmed our functional observation. In fact, to verify whether CARMA2 splice variants bind to BCL10, CARMA2<italic>sh</italic>, and CARMA2<italic>cl</italic> were co-expressed with BCL10, cell extracts were prepared, and were immunoprecipitated with anti-FLAG antibody. Immunoblotting experiments revealed that CARMA2<italic>sh</italic>, but not CARMA2<italic>cl</italic>, co-immunoprecipitated with BCL10 (<xref ref-type="fig" rid="fig03">Fig. 3C</xref>). The binding of CARMA2<italic>sh</italic> to BCL10 was dependent on an intact CARD of BCL10, because CARMA2<italic>sh</italic> failed to co-precipitate variants of BCL10 containing a point mutation L41Q or G78R that disrupts CARD/CARD interactions (Srinivasula et al., <xref ref-type="bibr" rid="b21">1999</xref>; Guiet and Vito, <xref ref-type="bibr" rid="b8">2000</xref>) (<xref ref-type="fig" rid="fig03">Fig. 3C</xref>). These results indicate that CARMA2<italic>sh</italic>, but not CARMA2<italic>cl</italic>, associates with BCL10 through a CARD/CARD homotypic interaction.</p>
      <p>We next determined the cellular localization of CARMA2<italic>sh</italic> and CARMA2<italic>cl</italic>. For this, we transfected HEK-293 cells with a FLAG-tagged vector encoding for these splice variants of CARMA2, and the expressed protein was detected using a monoclonal anti-FLAG antibody. The results of these experiments, shown in <xref ref-type="fig" rid="fig04">Figure 4</xref>, indicate that both CARMA2<italic>sh</italic> and CARMA2<italic>cl</italic> exhibit a clear pattern of diffuse cytoplasmic distribution.</p>
      <fig id="fig04" position="float">
        <label>Fig. 4</label>
        <caption>
          <p>Subcellular localization of <italic>CARMA2</italic> isoforms. HEK-293 (upper parts) and HeLa cells (lower parts) were transfected with mammalian FLAG-tagged vector, empty (vector) or expressing CARMA2<italic>sh</italic> or CARMA2<italic>cl</italic>. Sixteen hours after transfection, cells were stained with anti-FLAG mAb, followed by FITC-conjugated anti-mouse IgG.</p>
        </caption>
        <graphic xlink:href="jcp0226-3121-f4"/>
      </fig>
      <p>Interestingly, in a set of association experiments, we also found that immunocomplexes containing endogenous TRAF2, a scaffold protein that transduces signals from membrane receptors and the ER membrane (Rothe et al., <xref ref-type="bibr" rid="b19">1994</xref>; Yoneda et al., <xref ref-type="bibr" rid="b28">2001</xref>; Mauro et al., <xref ref-type="bibr" rid="b14">2006</xref>), also contain CARMA2 isoforms (<xref ref-type="fig" rid="fig05">Fig. 5A</xref>). To confirm association of CARMA2<italic>sh</italic> and TRAF2 in a different experimental system, a polypeptide corresponding to Met<sup>1</sup>-Glu<sup>126</sup> of CARMA2FL was expressed as His-tagged protein in bacteria and tested for binding to TRAF2 endogenously expressed. The results of these pull-down assays, shown in <xref ref-type="fig" rid="fig05">Figure 5B</xref>, indicate that recombinant CARMA2 Met<sup>1</sup>-Glu<sup>126</sup> binds to TRAF2 in lysates prepared from HEK-293 and Jurkat cells. Similar results were observed when lysates were prepared from HeLa cell (data not shown). In addition, coprecipitation experiments demonstrated that CARMA2<italic>sh</italic> also binds to TRAF3, TRAF6 but not TRAF7 (<xref ref-type="fig" rid="fig05">Fig. 5C</xref>). To further define the biological significance of CARMA2<italic>sh</italic> interaction with TRAF2, we tested the NF-ÎºB inducing activity of CARMA2<italic>sh</italic> in embryonic fibroblasts (MEFs) derived from TRAF2<sup>â/â</sup> mice and wt MEFs. As shown in <xref ref-type="fig" rid="fig05">Figure 5D</xref>, when CARMA2<italic>sh</italic> was expressed in wt MEFs, NF-ÎºB was induced 10- to 15-fold compared with empty vector. However, CARMA2<italic>sh</italic> was barely able to induce NF-ÎºB signaling in TRAF2<sup>â/â</sup> MEFs. Thus, a functional TRAF2 protein is required for activation of NF-ÎºB induced by CARMA2<italic>sh</italic> expression.</p>
      <fig id="fig05" position="float">
        <label>Fig. 5</label>
        <caption>
          <p>CARMA2<italic>sh</italic> binds to and activates NF-ÎºB through TRAF2. A: Lysates prepared from HeLa, HEK-293, or Jurkat cells were immunoprecipitated with anti-TRAF2 antibody or an isotype-matched antibody. Immunoprecipitating material was separated by SDSâPAGE and blotted onto membranes subsequently hybridized with anti-CARMA2 rabbit antiserum. B: Recombinant histidine-tagged CARMA2<sup>1â126</sup> was purified with nickelânitrilotriacetic acid-agarose beads and mixed with lysates from HEK-293 or Jurkat cells. After washing, agarose beads were boiled in SDS-sample buffer, separated by SDSâPAGE, and transferred onto nitrocellulose membrane probed with anti-TRAF2 antibody. C: HEK-293 cells were transiently cotransfected with a tagged version of CARMA2<italic>sh</italic> along with tagged version of members of TRAF proteins. Twenty-four hours later, cell lysates were immunoprecipitated with anti-FLAG mAb or anti-HA antisera. Immunocomplexes were separated by SDSâPAGE and transferred onto membranes subsequently probed with anti-HA antisera or anti-FLAG mAb. D: CARMA2<italic>sh</italic> fails to activate NF-ÎºB in TRAF2-deficient cells wt MEFs (left columns) and TRAF2<sup>â/â</sup> MEFs (right columns) were transfected with pNF-ÎºB-Luc, pCMV-Î²-gal, and the indicated expression plasmids. An expression vector coding for the NF-ÎºB subunit p65 served as positive control. Cells were harvested 24 h after transfection, and NF-ÎºB activity was determined. Data shown represents relative luciferase activity normalized on Î²-galactosidase activity and is representative of four independent experiments done in triplicate. Statistical analysis was by the one-tailed unpaired Student's <italic>t</italic>-test.</p>
        </caption>
        <graphic xlink:href="jcp0226-3121-f5"/>
      </fig>
      <p>Since TRAF2 regulates apoptotic signal transduction pathways starting from membrane receptors and the ER membrane (Rothe et al., <xref ref-type="bibr" rid="b19">1994</xref>; Yoneda et al., <xref ref-type="bibr" rid="b28">2001</xref>; Mauro et al., <xref ref-type="bibr" rid="b14">2006</xref>), we investigated the involvement of CARMA2<italic>sh</italic> in cell death induced by different stimuli. For this, we established HEK-293 cell lines that stably expressed FLAG-tagged CARMA2<italic>sh</italic> or CARMA2<italic>cl</italic> through a lentiviral expression system and then examined their responses to inducers of programmed cell death. The expression of ectopic CARMA2<italic>sh</italic> or CARMA2<italic>cl</italic> was assumed by immunoblot experiments; GFP is an irrelevant protein and here was used as a control. As shown in <xref ref-type="fig" rid="fig06">Figure 6A</xref>, expression of CARMA2<italic>sh</italic>, and partially that of CARMA2<italic>cl</italic>, confers resistance to apoptosis induced by thapsigargin, tunicamycin, and anisomycin treatment both in HEK-293 cells (<xref ref-type="fig" rid="fig06">Fig. 6A</xref>) and HeLa cells (<xref ref-type="fig" rid="fig06">Fig. 6B,C</xref>). Induction of ER stress was monitored by assessing the expression level of ER stress marker protein BiP (Dudek et al., <xref ref-type="bibr" rid="b3">2009</xref>). At a lesser extent, CARMA2<italic>sh</italic>, but not CARMA2<italic>cl</italic>, protects cells also from death induced by etoposide, staurosporine, and TNFÎ± treatment (data not shown).</p>
      <fig id="fig06" position="float">
        <label>Fig. 6</label>
        <caption>
          <p>CARMA2<italic>sh</italic> expression protects cells from apoptosis. A: HEK-293 cells infected with a lentiviral vector expressing the indicated cDNAs were exposed to the indicated drugs for 24 h and then analyzed for apoptosis using ATPLiteâ¢ kit analysis. Each data point represents the mean Â± SD cell survival expressed as percentage of untreated cells in six replicates. Statistical analysis was by the one-tailed unpaired Student's <italic>t</italic>-test. Bottom parts: Immunoblots analysis of expressed FLAG-tagged CARMA2<italic>sh</italic>, CARMA2<italic>cl</italic> in untreated cells, and cleaved PARP or BiP upon exposure to the drug. B: HeLa cells, stably transfected with an expression vector encoding for the indicated polypeptides, were treated and analyzed as in (A). Each data point represents the mean Â± SD cell survival expressed as percentage of untreated cells in six replicates. Statistical analysis was by the one-tailed unpaired Student's <italic>t</italic>-test. C: Phase contrast micrographs (20Ã) of HeLa cells stably expressing the indicated polypeptides and exposed for 24 h to the indicated drugs. D: HeLa cells infected with a lentiviral vectors expressing a shRNAs targeting CARMA2 were exposed to the indicated drugs for 24 h. Extent of cell death was assessed using the ATPLiteâ¢ kit. Each data point represents the mean Â± SD cell survival expressed as percentage of untreated cells in six replicates. Statistical analysis was by the one-tailed unpaired Student's <italic>t</italic>-test.</p>
        </caption>
        <graphic xlink:href="jcp0226-3121-f6"/>
      </fig>
      <p>To further assess the biological significance of CARMA2 in programmed cell death, CARMA2 expression was silenced by siRNA. We identified a siRNA which partially silenced CARMA2 expression in HeLa and HEK-293 cells (data not shown). When CARMA2 expression was silenced by this siRNA, apoptotic response was significantly increased compared to control siRNA (<xref ref-type="fig" rid="fig06">Fig. 6D</xref>). These results indicated that increased expression of CARMA2 has a protective role in apoptotic pathways.</p>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>In this work, we describe the identification and the functional characterization of two novel isoforms of CARMA2, namely CARMA2<italic>sh</italic> and CARMA2<italic>cl</italic>. The expression pattern of these newly identified transcripts is, however, different. In fact, while CARMA2<italic>sh</italic> appears to be expressed by the vast majority of cell lines analyzed, CARMA2<italic>cl</italic> appears to be expressed by few cell types (only 2 out of 14 cell lines analyzed). This suggests that the functions performed by the corresponding polypeptides might be different, namely CARMA2<italic>sh</italic> would play a biological function common to many cell types, whereas the function of CARMA2<italic>cl</italic> may be more cell-type specific. In addition, the two CARMA2 isoforms behave differently compared to CARMA2FL. In fact, while CARMA<italic>sh</italic>, similarly to CARMA2FL, retains the ability to activate NF-ÎºB, CARMA2<italic>cl</italic> is unable to positively regulate this transcription factor.</p>
      <p>The identification of these two alternative transcripts of CARMA2 is particularly intriguing for several aspects regarding the functional activity of CARMA2 and the CARMA proteins in a broader biological context. In fact, both CARMA2<italic>cl</italic> and CARMA2<italic>sh</italic> lack the SH3, PDZ, and GuK domains (MAGUK), which are essential for membrane localization and lipid raft recruitment of CARMA proteins (reviewed in Lin and Wang, <xref ref-type="bibr" rid="b13">2004</xref>; Thome, <xref ref-type="bibr" rid="b23">2004</xref>). This observation raises the interesting possibility that CARMA2<italic>sh</italic> and CARMA2<italic>cl</italic> may regulate signal transduction pathways of stimuli starting not from the cell membrane, but rather from intracellular compartments. Indeed, the most evident biological aspect that these two isoforms appear to affect is apoptosis induced by thapsigargin, tunicamycin, and anisomycin treatment. Both thapsigargin and tunicamycin induce ER stress by inhibiting ER-resident Ca2-ATPase, and N-glycosylation, respectively. Anisomycin is a translational inhibitor and strongly activates the stress-activated mitogen-activated protein (MAP) kinases pathway. Thus, altogether these observations are consistent with the hypothesis that these CARMA2 isoforms may regulate intracellular signals, particularly those arising from the ER. In this context, the finding that the functional activity of CARMA2<italic>sh</italic> relies on TRAF2 is undoubtedly relevant, since TRAF2 is involved in signaling from ER being able to interact with Ire1 (Urano et al., <xref ref-type="bibr" rid="b24">2000</xref>), one of the ER transmembrane proteins involved in initiating signals from the ER. In addition, TRAF2 mediates activation of both the JNK/SAPK and the NF-ÎºB pathways following ER stress (Urano et al., <xref ref-type="bibr" rid="b24">2000</xref>; Leonardi et al., <xref ref-type="bibr" rid="b12">2002</xref>; Mauro et al., <xref ref-type="bibr" rid="b14">2006</xref>). Therefore, we propose that while CARMA2FL similarly to CARMA1 and CARMA3 may transduce stimuli starting from the cell membrane, CARMA<italic>sh</italic> and CARMA<italic>cl</italic> transduce stimuli starting from intracellular compartments.</p>
      <p>The mechanism through which CARMA2<italic>sh</italic> protects cells from programmed cell death could obviously be related to the ability of this protein to induce activation of NF-ÎºB transcription factor, which is well known to regulate transcription of anti-apoptotic genes.</p>
      <p>However, it is evident that other protective mechanisms may exist, since even CARMA2<italic>cl</italic> partially protects from induced apoptosis, although unable to activate NF-ÎºB. Thus, one can assume that different CARMA2 isoforms might likely impact other functions of this protein, in addition to regulation of apoptosis and NF-ÎºB activation. In conclusion, our study revealed the existence of alternative splice variants of CARMA2, suggesting that the presence of distinct combinations of CARMA2 splice variants might potentially affect its biological activity. Clearly, there are many interesting question concerning CARMA2 function that require further investigation. In this context, the generation of animal models genetically modified in the locus encoding for CARMA2 will be certainly of enormous value to shed some light on the physiological role of this protein.</p>
    </sec>
    <sec sec-type="materials|methods">
      <title>Materials and Methods</title>
      <sec>
        <title>Reagents</title>
        <p>Sources of antibodies and reagents were the following: anti-FLAG, anti-HA Sigma (St. Louis, MO); anti-TRAF2, anti-BiP, anti-cleaved PARP Santa Cruz Biotechnology (Santa Cruz, CA); anti-BCL-10 antibody has been generated in our laboratory and has been described elsewhere (Guiet and Vito, <xref ref-type="bibr" rid="b8">2000</xref>). Thapsigargin, tunicamycin, anisomycin, staurosporine, etoposide, and human recombinant TNFÎ± were obtained from Sigma. ATPLiteâ¢ kit was purchased from PerkinElmer Corp. (Waltham, MA) and used according to the manufacturer's indication.</p>
        <p>The siRNA (<italic>Mission</italic>) directed to CARMA2 was from Sigma.</p>
        <p>Human cDNA (<italic>Marathon-Ready-cDNA</italic>) were obtained from Clontech (Mountain View, CA).</p>
      </sec>
      <sec>
        <title>Cell culture and transfection</title>
        <p>HEK293 and HeLa cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS. DNA plasmids were transfected into cultured cells by calciumâphosphate methods or using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. Jurkat cells were maintained in RPMI medium supplemented with 10% FBS. Retroviral infections were performed as previously described (Guiet et al., <xref ref-type="bibr" rid="b9">2002</xref>).</p>
      </sec>
      <sec>
        <title>RT-PCR</title>
        <p>Total RNA was isolated from cells or tissues using TRIzol reagent (Invitrogen). Expand High Fidelity PCR system (Roche, Basel, Switzerland) was used to amplify each of the CARMA2 splice variants. The reverse transcriptase reaction was performed using 1 Âµg of total RNA in a 20 Âµl reaction and 1 Âµl of the resulting cDNA was used in the subsequent amplification step along with 300 nM of each primer. To eliminate the possibility of genomic DNA contamination, RNA preparation was treated with RNase-free DNase. Amplification consisted of 42 cycles of 95Â°C for 30 s, 58Â°C for 25 s, 72Â°C for 40 s, and a final amplification step at 72Â°C for 5 min. The following oligos were utilized to amplify CARMA2FL: fwd: 5â²-GCCTGGCTCCTGACGG-3â²; rev: 5â²-TCGGGGGCTCTGCTCC-3â². The following oligos were utilized to amplify CARMA2<italic>sh</italic>: fwd: 5â²-<sc>caaagtggcgacctcggg</sc>-3â²; rev: 5â²-<sc>gcaatatataaagcatccatcac-3â².</sc> The following oligos were utilized to amplify CARMA2<italic>cl</italic>: fwd 5â²-TGTCCCGCGTTCCCAGCTG-3â²; rev: 5â²-CTCCCGCAGCGAGTGGATG-3â².</p>
      </sec>
      <sec>
        <title>Generation of <italic>CARMA2</italic> polyclonal antibody</title>
        <p>A DNA fragment encoding the fragment 108â497 of CARMA2FL was cloned into pET-28a (Novagen, San Diego, CA) to create an N-terminal Histidine-tagged fusion protein. The His fusion protein was purified by affinity chromatography on NichelâSepharose beads. Cell lysate preparation and purification of recombinant proteins were performed as recommended by the resin manufacturer (Sigma). The purified polypeptide was used for the immunization of rabbits to obtain polyclonal antibodies (InCura srl, Cremona, Italy).</p>
      </sec>
      <sec>
        <title>ATPLite assay</title>
        <p>A total of 8 Ã 10<sup>3</sup> cells per well were cultured in flat-bottom 96-well plate in quadruplicates in 10% FBS/DMEM medium. Cell viability was determined using ATPLiteâ¢ (PerkinElmer Corp.) kit according to the manufacturer's instructions.</p>
      </sec>
      <sec>
        <title>Transfections and NF-ÎºB activation assays</title>
        <p>4 Ã 10<sup>4</sup> HEK293 cells/well were plated in standard 24-well culture dishes and transfected with the reporter constructs pRSV-Î²-gal and pNF-ÎºB-Luc plus the indicated expression plasmids using the calcium phosphate method. The total amount of transfected plasmid DNA was adjusted with pcDNA3 vector such that it was constant within each individual experiment. NF-ÎºB activation was assessed by measuring luciferase activity (normalized for Î²-galactosidase expression) in cell extracts 16 h after transfection.</p>
        <p>Wild-type (WT) and TRAF2<sup>â/â</sup> murine embryonic fibroblasts (MEFs) were provided by Dr. T.W. Mak and Dr. W.C. Yeh (Yeh et al., <xref ref-type="bibr" rid="b27">1997</xref>). For transfections of WT and TRAF2<sup>â/â</sup> MEFs, 4 Ã 10<sup>4</sup> cells/well were plated in 24-well culture 24 h prior to transfection. Expression and reporter plasmids were transfected using the Attractene (Qiagen, Milano, Italy). The cells were lysed and assayed 24 h after transfection using the luciferase assay system (Promega, Madison, WI) according to the manufacturer's instructions.</p>
      </sec>
      <sec>
        <title>Immunofluorescence</title>
        <p>1 Ã 10<sup>4</sup> HEK293 or HeLa cells were grown and transfected in chamber slides. Sixteen hours after transfection, cells were fixed in 4% paraformaldehyde for 15 min at room temperature and then permeabilized in PBS/0.1% Triton X-100. Cells were incubated for 30 min in 5% FCSâPBS with primary antibodies were, followed by several washes with 5% FCSâPBS, and then incubating for 30 min with secondary antibody in 5% FCSâPBS. All steps were done at room temperature.</p>
      </sec>
      <sec>
        <title>Immunoblot analysis and coprecipitation</title>
        <p>Cell lysates were made in lysis buffer (150 mM NaCl, 20 mM Hepes, pH 7.4, 1% Triton X-100, 10% glycerol, and a mixture of protease inhibitors). Proteins were separated by SDSâPAGE, transferred onto nitrocellulose membrane, and incubated with primary antibodies followed by horseradish peroxidase-conjugated secondary antibodies (Amersham Biosciences, Piscataway, NJ). Blots were developed using the ECL system (Amersham Biosciences). For co-immunoprecipitation experiments, cells were lysed in lysis buffer and immunocomplexes were bound to protein A/G, resolved by SDSâPAGE, and analyzed by immunoblot assay.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <p>We thank Dr. Antonella Fierro and Mariano Amoroso for technical assistance; Dr. Francesco Morra, Dr. Mariachiara Masone, Dr. Nilde De Sio, and Dr. Rosalia Russo for support; Prof. V. Colantuoni and Prof. G. Viglietto for providing cell lines. This work was in part supported by the Telethon grant GGP08125B to P. V.</p>
    </ack>
    <ref-list>
      <title>Literature Cited</title>
      <ref id="b1">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bertin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Jacobson</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Poyet</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Srinivasula</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Merriam</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>DiStefano</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Alnemri</surname>
              <given-names>ES</given-names>
            </name>
          </person-group>
          <article-title>CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B</article-title>
          <source>J Biol Chem</source>
          <year>2001</year>
          <volume>276</volume>
          <fpage>11877</fpage>
          <lpage>11882</lpage>
          <pub-id pub-id-type="pmid">11278692</pub-id>
        </element-citation>
      </ref>
      <ref id="b2">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dimitratos</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Woods</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Stathakis</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Bryant</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Signaling pathways are focused at specialized regions of the plasma membrane by scaffolding proteins of the MAGUK family</article-title>
          <source>Bioessays</source>
          <year>1999</year>
          <volume>21</volume>
          <fpage>912</fpage>
          <lpage>921</lpage>
          <pub-id pub-id-type="pmid">10517864</pub-id>
        </element-citation>
      </ref>
      <ref id="b3">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dudek</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Benedix</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cappel</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Greiner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jalal</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>MÃ¼ller</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Zimmermann</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Functions and pathologies of BiP and its interaction partners</article-title>
          <source>Cell Mol Life Sci</source>
          <year>2009</year>
          <volume>66</volume>
          <fpage>1556</fpage>
          <lpage>1569</lpage>
          <pub-id pub-id-type="pmid">19151922</pub-id>
        </element-citation>
      </ref>
      <ref id="b4">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Egawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Albrecht</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Favier</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sunshine</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Mirchandani</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>O'Brien</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Thome</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Littman</surname>
              <given-names>DR</given-names>
            </name>
          </person-group>
          <article-title>Requirement for CARMA1 in antigen receptor-induced NF-kappa B activation and lymphocyte proliferation</article-title>
          <source>Curr Biol</source>
          <year>2003</year>
          <volume>13</volume>
          <fpage>1252</fpage>
          <lpage>1258</lpage>
          <pub-id pub-id-type="pmid">12867038</pub-id>
        </element-citation>
      </ref>
      <ref id="b5">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gaide</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Martinon</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Micheau</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Bonnet</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Thome</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tschopp</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-kappaB activation</article-title>
          <source>FEBS Lett</source>
          <year>2001</year>
          <volume>496</volume>
          <fpage>121</fpage>
          <lpage>127</lpage>
          <pub-id pub-id-type="pmid">11356195</pub-id>
        </element-citation>
      </ref>
      <ref id="b6">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gaide</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Favier</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Legler</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Bonnet</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Brissoni</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Valitutti</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bron</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tschopp</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Thome</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation</article-title>
          <source>Nat Immunol</source>
          <year>2002</year>
          <volume>3</volume>
          <fpage>836</fpage>
          <lpage>843</lpage>
          <pub-id pub-id-type="pmid">12154360</pub-id>
        </element-citation>
      </ref>
      <ref id="b7">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grabiner</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Blonska</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>You</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Darnay</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Dong</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation</article-title>
          <source>Genes Dev</source>
          <year>2007</year>
          <volume>21</volume>
          <fpage>984</fpage>
          <lpage>996</lpage>
          <pub-id pub-id-type="pmid">17438001</pub-id>
        </element-citation>
      </ref>
      <ref id="b8">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guiet</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Vito</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Caspase recruitment domain (CARD)-dependent cytoplasmic filaments mediate bcl10-induced NF-kappaB activation</article-title>
          <source>J Cell Biol</source>
          <year>2000</year>
          <volume>148</volume>
          <fpage>1131</fpage>
          <lpage>1140</lpage>
          <pub-id pub-id-type="pmid">10725326</pub-id>
        </element-citation>
      </ref>
      <ref id="b9">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guiet</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Silvestri</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>De Smaele</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Franzoso</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Vito</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>c-FLIP efficiently rescues TRAF-2â/â cells from TNF-induced apoptosis</article-title>
          <source>Cell Death Differ</source>
          <year>2002</year>
          <volume>9</volume>
          <fpage>138</fpage>
          <lpage>144</lpage>
          <pub-id pub-id-type="pmid">11840164</pub-id>
        </element-citation>
      </ref>
      <ref id="b10">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hara</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wada</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Bakal</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kozieradzki</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Nghiem</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Griffiths</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Krawezyk</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bauer</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>D'Acquisto</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ghosh</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yeh</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Baier</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rottapet</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Penninger</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>The MAGUK family protein CARD11 is essential for lymphocyte activation</article-title>
          <source>Immunity</source>
          <year>2003</year>
          <volume>18</volume>
          <fpage>763</fpage>
          <lpage>775</lpage>
          <pub-id pub-id-type="pmid">12818158</pub-id>
        </element-citation>
      </ref>
      <ref id="b11">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jun</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Vinuesa</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Lesage</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Blery</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Miosge</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Cook</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Kucharska</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Hara</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Penninger</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Domashenz</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Glynne</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Nelms</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Goodnow</surname>
              <given-names>CC</given-names>
            </name>
          </person-group>
          <article-title>Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis</article-title>
          <source>Immunity</source>
          <year>2003</year>
          <volume>18</volume>
          <fpage>751</fpage>
          <lpage>762</lpage>
          <pub-id pub-id-type="pmid">12818157</pub-id>
        </element-citation>
      </ref>
      <ref id="b12">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leonardi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vito</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Mauro</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Pacifico</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ulianich</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Consiglio</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Formisano</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Di Jeso</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Endoplasmic reticulum stress causes thyroglobulin retention in this organelle and triggers activation of nuclear factor-kappa B via tumor necrosis factor receptor-associated factor 2</article-title>
          <source>Endocrinology</source>
          <year>2002</year>
          <volume>143</volume>
          <fpage>2169</fpage>
          <lpage>2177</lpage>
          <pub-id pub-id-type="pmid">12021180</pub-id>
        </element-citation>
      </ref>
      <ref id="b13">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>The roles of CARMA1, Bcl10, and MALT1 in antigen receptor signaling</article-title>
          <source>Semin Immunol</source>
          <year>2004</year>
          <volume>16</volume>
          <fpage>429</fpage>
          <lpage>435</lpage>
          <pub-id pub-id-type="pmid">15541657</pub-id>
        </element-citation>
      </ref>
      <ref id="b14">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mauro</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Crescenzi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>De Mattia</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pacifico</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Mellone</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Salzano</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>de Luca</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>D'Adamio</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Palumbo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Formisano</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Vito</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Leonardi</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Central role of the scaffold protein tumor necrosis factor receptor-associated factor 2 in regulating endoplasmic reticulum stress-induced apoptosis</article-title>
          <source>J Biol Chem</source>
          <year>2006</year>
          <volume>281</volume>
          <fpage>2631</fpage>
          <lpage>2638</lpage>
          <pub-id pub-id-type="pmid">16299380</pub-id>
        </element-citation>
      </ref>
      <ref id="b15">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McAllister-Lucas</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Inohara</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Lucas</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Ruland</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Benito</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>FF</given-names>
            </name>
            <name>
              <surname>Yamaoka</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Verma</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Mak</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>NÃºÃ±ez</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction</article-title>
          <source>J Biol Chem</source>
          <year>2001</year>
          <volume>276</volume>
          <fpage>30589</fpage>
          <lpage>30597</lpage>
          <pub-id pub-id-type="pmid">11387339</pub-id>
        </element-citation>
      </ref>
      <ref id="b16">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McAllister-Lucas</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Jin</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Gu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Siu</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>McDonnell</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ruland</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Delekta</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Van Beek</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lucas</surname>
              <given-names>PC</given-names>
            </name>
          </person-group>
          <article-title>CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2007</year>
          <volume>104</volume>
          <fpage>139</fpage>
          <lpage>144</lpage>
          <pub-id pub-id-type="pmid">17101977</pub-id>
        </element-citation>
      </ref>
      <ref id="b17">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Newton</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Dixit</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Mice lacking the CARD of CARMA1 exhibit defective B lymphocyte development and impaired proliferation of their B and T lymphocytes</article-title>
          <source>Curr Biol</source>
          <year>2003</year>
          <volume>13</volume>
          <fpage>1247</fpage>
          <lpage>1251</lpage>
          <pub-id pub-id-type="pmid">12867037</pub-id>
        </element-citation>
      </ref>
      <ref id="b18">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pomerantz</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Denny</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Baltimore</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>CARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex</article-title>
          <source>EMBO J</source>
          <year>2002</year>
          <volume>21</volume>
          <fpage>5184</fpage>
          <lpage>5194</lpage>
          <pub-id pub-id-type="pmid">12356734</pub-id>
        </element-citation>
      </ref>
      <ref id="b19">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rothe</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Henzel</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Goeddel</surname>
              <given-names>DV</given-names>
            </name>
          </person-group>
          <article-title>A novel family of putative signal transducers associated with the cytoplasmic domain of the 75kDa tumor necrosis factor receptor</article-title>
          <source>Cell</source>
          <year>1994</year>
          <volume>78</volume>
          <fpage>681</fpage>
          <lpage>692</lpage>
          <pub-id pub-id-type="pmid">8069916</pub-id>
        </element-citation>
      </ref>
      <ref id="b20">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schulze-Luehrmann</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ghosh</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Antigen-receptor signaling to nuclear factor kappa B</article-title>
          <source>Immunity</source>
          <year>2006</year>
          <volume>25</volume>
          <fpage>701</fpage>
          <lpage>715</lpage>
          <comment>Review</comment>
          <pub-id pub-id-type="pmid">17098202</pub-id>
        </element-citation>
      </ref>
      <ref id="b21">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Srinivasula</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Ahmad</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Poyet</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Fernandes-Alnemri</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tsichlis</surname>
              <given-names>PN</given-names>
            </name>
            <name>
              <surname>Alnemri</surname>
              <given-names>ES</given-names>
            </name>
          </person-group>
          <article-title>CLAP, a novel caspase recruitment domain-containing protein in the tumor necrosis factor receptor pathway, regulates NF-kappaB activation and apoptosis</article-title>
          <source>J Biol Chem</source>
          <year>1999</year>
          <volume>274</volume>
          <fpage>17946</fpage>
          <lpage>17954</lpage>
          <pub-id pub-id-type="pmid">10364242</pub-id>
        </element-citation>
      </ref>
      <ref id="b22">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stilo</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Varricchio</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Liguoro</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Leonardi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vito</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>A20 is a negative regulator of BCL10- and CARMA3-mediated activation of NF-kappaB</article-title>
          <source>J Cell Sci</source>
          <year>2008</year>
          <volume>121</volume>
          <fpage>1165</fpage>
          <lpage>1171</lpage>
          <pub-id pub-id-type="pmid">18349075</pub-id>
        </element-citation>
      </ref>
      <ref id="b23">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thome</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>CARMA1, BCL-10 and MALT1 in lymphocyte development and activation</article-title>
          <source>Nat Rev Immunol</source>
          <year>2004</year>
          <volume>4</volume>
          <fpage>348</fpage>
          <lpage>359</lpage>
          <pub-id pub-id-type="pmid">15122200</pub-id>
        </element-citation>
      </ref>
      <ref id="b24">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Urano</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Bertolotti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Harding</surname>
              <given-names>HP</given-names>
            </name>
            <name>
              <surname>Ron</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1</article-title>
          <source>Science</source>
          <year>2000</year>
          <volume>287</volume>
          <fpage>664</fpage>
          <lpage>666</lpage>
          <pub-id pub-id-type="pmid">10650002</pub-id>
        </element-citation>
      </ref>
      <ref id="b25">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Ke</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Poyet</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Manji</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Merriam</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Glucksmann</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>DiStefano</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Alnemri</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Bertin</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Card10 is a novel caspase recruitment domain/membrane-associated guanylate kinase family member that interacts with BCL10 and activates NF-kappa B</article-title>
          <source>J Biol Chem</source>
          <year>2001</year>
          <volume>276</volume>
          <fpage>21405</fpage>
          <lpage>21409</lpage>
          <pub-id pub-id-type="pmid">11259443</pub-id>
        </element-citation>
      </ref>
      <ref id="b26">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>You</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Case</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>McAllister-Lucas</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>DiStefano</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>NÃºÃ±ez</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bertin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>A requirement for CARMA1 in TCR-induced NF-kappa B activation</article-title>
          <source>Nat Immunol</source>
          <year>2002</year>
          <volume>3</volume>
          <fpage>830</fpage>
          <lpage>835</lpage>
          <pub-id pub-id-type="pmid">12154356</pub-id>
        </element-citation>
      </ref>
      <ref id="b27">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yeh</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Shahinian</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Speiser</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kraunus</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Billia</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Wakeham</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>de la Pompa</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Ferrick</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hum</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Iscove</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ohashi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Rothe</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Goeddel</surname>
              <given-names>DV</given-names>
            </name>
            <name>
              <surname>Mak</surname>
              <given-names>TW</given-names>
            </name>
          </person-group>
          <article-title>Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice</article-title>
          <source>Immunity</source>
          <year>1997</year>
          <volume>7</volume>
          <fpage>715</fpage>
          <lpage>725</lpage>
          <pub-id pub-id-type="pmid">9390694</pub-id>
        </element-citation>
      </ref>
      <ref id="b28">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yoneda</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Imaizumi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Oono</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yui</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gomi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Katayama</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tohyama</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress</article-title>
          <source>J Biol Chem</source>
          <year>2001</year>
          <volume>276</volume>
          <fpage>13935</fpage>
          <lpage>13940</lpage>
          <pub-id pub-id-type="pmid">11278723</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>